Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
US Army
Julphar
Cantor Fitzgerald
Argus Health
Chubb
Cipla
Medtronic
Queensland Health

Generated: April 23, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 203923

« Back to Dashboard

NDA 203923 describes SODIUM THIOSULFATE, which is a drug marketed by Us Army and Hope Pharms and is included in two NDAs. It is available from one supplier. There are three patents protecting this drug. Additional details are available on the SODIUM THIOSULFATE profile page.

The generic ingredient in SODIUM THIOSULFATE is sodium thiosulfate. There are one thousand four hundred and twenty-six drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the sodium thiosulfate profile page.
Summary for 203923
Tradename:SODIUM THIOSULFATE
Applicant:Hope Pharms
Ingredient:sodium thiosulfate
Patents:3
Formulation / Manufacturing:see details
Suppliers and Packaging for NDA: 203923
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
SODIUM THIOSULFATE sodium thiosulfate SOLUTION;INTRAVENOUS 203923 NDA Hope Pharmaceuticals 60267-705 N 60267-705-50

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:SOLUTION;INTRAVENOUSStrength12.5GM/50ML (250MG/ML)
Approval Date:Feb 14, 2012TE:RLD:Yes
Regulatory Exclusivity Expiration:Jan 14, 2018
Regulatory Exclusivity Use:FOR SEQUENTIAL USE FOR THE TREATMENT OF CYANIDE POISONING THAT IS JUDGED TO BE LIFE-THREATENING
Patent:➤ Try a Free TrialPatent Expiration:Mar 29, 2031Product Flag?YSubstance Flag?YDelist Request?
Patented Use:TREATMENT OF ACUTE CYANIDE POISONING THAT IS JUDGED TO BE LIFE THREATENING
Patent:➤ Try a Free TrialPatent Expiration:Mar 29, 2031Product Flag?YSubstance Flag?YDelist Request?
Patented Use:SODIUM THIOSULFATE INJECTION IS INDICATED FOR SEQUENTIAL USE WITH SODIUM NITRITE FOR THE TREATMENT OF ACUTE CYANIDE POISONING

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Chubb
Julphar
McKesson
US Department of Justice
US Army
Queensland Health
UBS
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.